Cargando…
The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients
BACKGROUND AND AIM: This study investigated the risk of the development of primary biliary cholangitis (PBC) in individuals who were incidentally identified as having positive antimitochondrial antibodies (AMA)-M2. MATERIALS AND METHODS: We retrospectively reviewed extractable nuclear antibody (ENA)...
Autores principales: | Ergenc, Ilkay, Gozaydinoglu, Busra, Keklikkiran, Caglayan, Yilmaz, Yusuf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209978/ https://www.ncbi.nlm.nih.gov/pubmed/37250930 http://dx.doi.org/10.14744/hf.2023.2023.0016 |
Ejemplares similares
-
Antimitochondrial Antibody-Negative Primary Biliary Cholangitis: A Retrospective Diagnosis
por: Al-Handola, Rami, et al.
Publicado: (2023) -
Antimitochondrial antibody associated with liver cirrhosis in patients with primary biliary cholangitis
por: Jin, Yujiao, et al.
Publicado: (2023) -
Meta-Analysis of Antinuclear Antibodies in the Diagnosis of Antimitochondrial Antibody-Negative Primary Biliary Cholangitis
por: Zhang, Qian, et al.
Publicado: (2019) -
Negative conversion of antimitochondrial antibody in primary biliary cirrhosis: a case of autoimmune cholangitis.
por: Cho, Y. J., et al.
Publicado: (1999) -
Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell Arteritis
por: Manzo, Ciro, et al.
Publicado: (2021)